Skip to main content
Equibles
BQST logo

BQST · Bioquest Corp

Track BQST — free

Use BQST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BQST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.25 At close · Oct 14
Rebalance outlook locked
Going-concern doubt — flagged Sep 12, 2022

Substantial doubt about the company's ability to continue as a going concern.

“As reflected in the accompanying financial statements, the Company had an accumulated deficit as of July 31, 2022, of $10,788,321 and its liabilities exceeded its assets by $536,419 These factors among others raise substantial doubt about the Company’s ability to continue as a going concern.”
View the 10-Q filed Sep 12, 2022
Market Cap
$7.47M
Shares
29.90M
Volume · Oct 14 67.47K Avg daily vol (3 sessions) 22.69K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.25 Open$0.25 Day$0.25–0.25 52W close$0.07–1.00 Avg vol 30d4K Short int40 · 0.0% of shares · 1.0d Short vol100% DataJan 2020–Oct 2026 Filing10-Q · Sep 12

Latest documents

2022
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$30,977
Trailing 12 months
Net income (TTM)
−$507,406
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$14,955
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+38.8%
Year over year · more shares
Price change (1Y)
-75.0%
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −71%
below
RSI (14) 36
neutral
MACD trend Negative
52-week position 20%
mid-range
Momentum
relative strength
Very Weak
1-month return −76%
trailing
6-month return −80%
trailing
YTD return −51%
this year
Relative strength −89%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · ▲ +300.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 4594%
annualized · 1-yr
Max drawdown −100%
past year
ATR 69.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−71% Bearish
RSI (14)
36 Neutral
MACD trend
Negative Bearish
52-week position
20% Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of shares out · ▲ +300.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 20% Range high $1
vs 50-day avg -71%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Software - Infrastructure — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BQST
Bioquest Corp
this stock
$7.47M — — — 0.0%
MSFT
Microsoft Corp
 $3.88T +8.1% +6.9% 27.3 0.8%
PLTR
Palantir Technologies Inc.
 $413.42B -3.5% +56.2% 120.0 2.3%
ORCL
Oracle Corp
 $384.35B -34.8% +17.3% 19.9 1.5%
PANW
Palo Alto Networks Inc
 $263.94B +75.2% +29.0% — 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
40
Days to cover
1.0d
Change
+30 sh
View
Short Volume
Short vol %
100%
As of
Nov 9, 2026
Short Total
View
Fails to Deliver
FTD shares
10
Value
$10
As of
May 15, 2025
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 5, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-821.0K
View
Filings
SEC Filings
Latest
NT 10-Q
Filed
Dec 7, 2022
This year
0
View

Performance

5D 20D 120D MTD YTD
BQST +278.8% -76.0% -80.0% +273.1% -51.1%
SPY -1.0% +2.1% +8.6% +0.9% +12.9%
vs SPY +279.8% -78.0% -88.6% +272.2% -63.9%
Key facts CIK 1568628 Visit website